메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

NYSE Content Advisory: Pre-Market Update + ESPN celebrates streaming service launch

NEW YORK, Aug. 21, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + ESPN celebrates streaming service launch Ashley Mastronardi delivers the pre-market update on August 21st Stocks are lower this morning as the S&P 500 looks to end a four-day losing streak amid recent pressure on the tech sector. The Federal Reserve remains in focus for Wall Street as the Centr
- 황정호 기자
- 2025-08-21 20:55
ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment

Fully integrated AI decision support tool flags B scans that may require further review, supporting more confident decision making and more efficient patient care. JENA, Germany, Aug. 21, 2025 -- ZEISS Medical Technology today announced CE mark approval for CIRRUS® PathFinder™, an innovative clinical support tool with artificial intelligence (AI) fully integrated to enable more confident decision-making and accelerate a clinician's workflow with OCT interpretation assistance. ZEISS CIRRUS PathFinder1 uses proprietary deep learning algorithms to automatically identify abnorm
- 김갑성 기자
- 2025-08-21 20:00
From "Market Blindness" to "Investor Magnet": Korean PropTech Game Changer Wins Over 50 Clients Including GIC and DWS in Just 8 Months

SEOUL, South Korea, Aug. 21, 2025 -- Korean PropTech startup RSQUARE's RA (Rsquare Analytics) solution is reshaping how global investors view the Korean commercial real estate market. Until recently the market forced multi-million-dollar investment decisions to be made with limited transparency. Investors had to contact dozens of brokers or rely on personal networks to obtain even basic data such as prime office rent or vacancy rates. The information gathered was often inconsistent, keeping foreign capital away for decades. In 2023 RSQUARE launched RA, a platform recognized as a
- 황정호 기자
- 2025-08-21 20:00
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health

Company holds a dedicated meeting with Gates Foundation executives during Bill Gates' visit to Korea. Both reviews expanded cooperation, including next-generation preventive medicines. SEONGNAM, South Korea, Aug. 21, 2025 -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that the company held an exclusive meeting with the Gates Foundation in line with the visit of Bill Gates, Founder and Chair of the Foundation, to Korea to discuss ways to advance global health collaboration.&nbs
- 김갑성 기자
- 2025-08-21 20:00
BioDlink's Bevacizumab Approved for Market Launch in Indonesia, Marking Fourth Consecutive Emerging Market Authorization

Bevacizumab Injection officially approved by Indonesia's National Agency of Drug and Food Control (BPOM), following Nigeria, Pakistan, and Colombia – accelerating global commercialization Approval in ASEAN's largest pharma market strengthens BioDlink's position as a global supplier of antibody/XDC therapies via international GMP standards and commercial capabilities SUZHOU, China, Aug. 21, 2025 -- BioDlink announced that its Bevacizumab Injection has obtained marketing authorization from Indonesia's National Agency of Drug and Food Control (BPOM). This mark
- 김갑성 기자
- 2025-08-21 20:00
FDA clearance of Salix® Coronary Plaque module

[ 메디채널 김갑성 기자 ] Significantly expands U.S. commercial opportunity with ability to charge fees per scan assessed Investor Webinar - 11.30am AEST (9.30am AWST) on 22 August 2025 PERTH, Australia, Aug. 21, 2025 -- Artrya Limited (ASX: AYA) (Artrya or the Company), a medical technology company commercialising its Salix® AI-powered cloud platform, for the near real time, point of care assessment and management of coronary artery disease, is pleased to announce it has received 510(k) clearance from the U.S. Food and Drug Administration (the FDA) for Artrya's proprietary, Salix&r
- 김갑성 기자
- 2025-08-21 19:43
FNZ reaches record milestone of US$2 trillion in Assets on Platform

[ 메디채널 황정호 기자 ] Assets on Platform have grown by 406% over the last five years This milestone reinforces FNZ's position as one of the world's largest wealth management platforms FNZ now partners with over 650 financial institutions, more than 12,000 wealth management firms and serves over 26 million end investors globally 6 out of the top 10 most recommended UK adviser platforms use FNZ technology, according to recent analysis conducted by Defaqto Builds on FNZ's purpose to open up wealth by making wealth management more accessible and personalized to more people LONDON and
- 황정호 기자
- 2025-08-21 19:33
Transforming Entertainment Experience with AI: iQIYI's iJump Feature Surpasses 150 Million Interactions in 120 Days

BEIJING, Aug. 21, 2025 -- On August 21, iQIYI, China's leading online entertainment platform, proudly announced a major milestone for its groundbreaking AI-powered feature, iJump. Since launching on April 21, 2024, iJump has recorded over 150 million user interactions within just 120 days, signaling rapid adoption and a fresh way viewers are engaging with long-form content. iJump was created in response to evolving viewer preferences, this innovative tool allows users to effortlessly jump between key scenes and story highlights. Powered by sophisticated AI, iJump
- 김장윤(JASON KIM) 기자
- 2025-08-21 18:49
Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results

Multiple Ongoing Phase 2b Studies Advancing HBV Functional Cure Strategy Greater China Partnership with Joincare to Accelerate Development of Critical Care Antibiotic soralimixin Strong Cash Position to Pursue New Discovery Opportunities and Partnership Strategy Conference Calls Scheduled: English Session: August 21 at 9:00 p.m. HKT / 9:00 a.m. ET Chinese Session: August 22 at 9:00 a.m. HKT / August 21 at 9:00 p.m. ET DURHAM, N.C., and BEIJING, Aug. 21, 2025 -- Brii Biosciences Limited ("Brii Bio," or the "Company," stock code: 2137.HK),
- 김갑성 기자
- 2025-08-21 18:02
BeeWeave Announces Launch of Equity Incentive Management System, Prepares for Nasdaq Listing

BEIJING, Aug. 21, 2025 -- On August 20, Beijing Bee Weaving Network Technology Co., Ltd. ("Bee Weaving") announced the official launch of its Equity Incentive Management System, marking a key milestone in the company's long-term capitalization strategy. The initiative is designed to drive business expansion and technological innovation through a dual focus on talent incentives and capital deployment, strengthening Bee Weaving's leadership position in the biotech and AI sectors. Bee Weaving has also begun preparations for an RTO (Reverse Takeover) asset restructuring, with the
- 황정호 기자
- 2025-08-21 18:02

이전

51 52 53 54 55 56 57 58 59 60

많이 본 기사

최근기사

2025-09-06_SAT

2025-09-05_FRI

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 06일 06시 40분